Support for developing vaccines and biologics for infectious diseases

Task V01: Administrative Support for Evaluation and Testing Services (ETS) for Vaccines and other Biologics for Infectious Diseases

['FUNDING_OTHER'] · BATTELLE CENTERS/PUB HLTH RES & EVALUATN · NIH-11140930

This study is all about helping create new vaccines to fight infectious diseases, including those that could come from bioterrorism, so that patients like you can have access to safe and effective vaccines in the future.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorBATTELLE CENTERS/PUB HLTH RES & EVALUATN (nih funded)
Locations1 site (COLUMBUS, UNITED STATES)
Trial IDNIH-11140930 on ClinicalTrials.gov

What this research studies

This research focuses on providing essential administrative and technical support for the development of vaccines and biologics aimed at combating infectious diseases, including those that may arise from bioterrorism. It involves conducting feasibility studies, training workshops, and quality oversight to ensure that new vaccine candidates meet regulatory standards. The project also includes testing for immunogenicity and efficacy, as well as safety assessments, to facilitate the submission of necessary applications for new drug approvals. Patients may benefit from the eventual availability of new vaccines that are developed through this comprehensive support system.

Who could benefit from this research

Good fit: Ideal candidates for participation or benefit from this research include individuals at risk for emerging infectious diseases or those who may be affected by bioterrorism.

Not a fit: Patients with established vaccines for their conditions or those not at risk for infectious diseases may not receive direct benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of new vaccines that protect against serious infectious diseases.

How similar studies have performed: Previous research has shown success in developing vaccines through similar administrative and technical support frameworks.

Where this research is happening

COLUMBUS, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Communicable Diseases, Emerging Communicable Diseases

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.